Acrivon TherapeuticsACRV
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 44 institutions reported holding Acrivon Therapeutics Inc. (ACRV) in their 13F filings, down 4 from Q4 2025. 7 opened new positions and 12 sold out. The largest holders were Ra Capital Management, L.P. ($11.6M), Sands Capital Alternatives, LLC ($3.0M) and Wellington Management Group LLP ($1.2M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Acrivon Therapeutics Inc.
- CUSIP
- 004890109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $334K |
| Exits | 12 | $5.5M |
All 13F filers, Q4 2025 → Q1 2026: 912,171 shares bought and 3,088,189 shares sold, net −2,176,018 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 44 holders
| Ra Capital Management, L.P. | 0.12% | No change | 8,340,508 | $11.6M |
| Sands Capital Alternatives, LLC | 0.70% | No change | 2,122,605 | $3.0M |
| Wellington Management Group LLP | 0.00% | No change | 888,130 | $1.2M |
| Acadian Asset Management LLC | 0.00% | Add +45.5% | 845,973 | $1.2M |
| Renaissance Technologies | 0.00% | Add +19.6% | 758,440 | $1.1M |
| Vanguard Capital Management LLC | 0.00% | — | 722,035 | $1.0M |
| Marshall Wace, LLP | 0.00% | Add +13.0% | 560,436 | $779K |
| Two Sigma Investments, LP | 0.00% | Reduce -33.4% | 389,395 | $541K |
| Jane Street Group, LLC | 0.00% | Reduce -29.9% | 239,691 | $333K |
| Geode Capital Management, LLC | 0.00% | Add +19.3% | 236,391 | $329K |
| BlackRock, Inc. | 0.00% | Add +1.9% | 208,939 | $290K |
| Gsa Capital Partners LLP | 0.02% | New | 186,716 | $260K |
| Bridgeway Capital Management, LLC | 0.00% | Add +270.4% | 158,900 | $221K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 107,529 | $149K |
| State Street Corp. | 0.00% | No change | 67,145 | $93K |
| XTX Topco Ltd | 0.00% | Add +225.1% | 66,882 | $93K |
| Northern Trust Corp. | 0.00% | Reduce -23.3% | 48,902 | $68K |
| Morgan Stanley | 0.00% | Reduce -21.7% | 36,671 | $51K |
| UBS Group AG | 0.00% | Reduce -90.1% | 34,634 | $48K |
| Panagora Asset Management Inc. | 0.00% | New | 33,814 | $47K |
| Squarepoint Ops LLC | 0.00% | Add +5.0% | 27,472 | $38K |
| Prelude Capital Management, LLC | 0.00% | Reduce -50.0% | 24,015 | $33K |
| Marex Group Ltd | 0.00% | Add +100.0% | 20,000 | $28K |
| Dimensional Fund Advisors LP | 0.00% | No change | 18,364 | $25K |
| Bank of America Corp. | 0.00% | Reduce -5.3% | 16,513 | $23K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -87.7% | 14,742 | $20K |
| Two Sigma Securities, LLC | 0.00% | New | 11,679 | $16K |
| AAF Wealth Management, LLC | 0.01% | No change | 10,678 | $15K |
| FMR LLC | 0.00% | Add +9.3% | 9,422 | $13K |
| Federated Hermes, Inc. | 0.00% | Add +41.2% | 7,924 | $11K |
| Barclays PLC | 0.00% | Reduce -75.7% | 5,940 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 4,526 | $6K |
| Vanguard Global Advisers, LLC | 0.00% | — | 4,453 | $6K |
| Wells Fargo & Company | 0.00% | New | 3,000 | $4K |
| BNP Paribas Financial Markets | 0.00% | No change | 634 | $881 |
| JPMorgan Chase & Co. | 0.00% | Reduce -96.2% | 638 | $823 |
| Nisa Investment Advisors, LLC | 0.00% | No change | 584 | $812 |
| Redwood Park Advisors LLC | 0.00% | No change | 500 | $695 |
| Russell Investments Group, Ltd. | 0.00% | No change | 481 | $669 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 400 | $556 |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 326 | $453 |
| SBI Securities Co., Ltd. | 0.00% | No change | 74 | $103 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 4 | $6 |
| Royal Bank of Canada | 0.00% | Reduce -98.5% | 25 | $0 |
"% of holder's portfolio" is ACRV's weight in each manager's 13F, not the share of Acrivon Therapeutics Inc. the manager owns.